Neurochem Submits First Unit Of Fibrillex Rolling NDA
This article was originally published in The Pink Sheet Daily
Executive Summary
The amyloid A amyloidosis agent is part of the Pilot 1 and Pilot 2 programs overseen by FDA's Division of Cardio-Renal Drug Products.